חזרה לתוצאות החיפוש

Study to Evaluate the Safety and Efficacy of Oral NRC-2694-A in Combination With Paclitaxel in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, Who Progressed on or After Immune Checkpoint Inhibitor Therapy

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Carcinoma · Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • Providence Medical Foundation -Fullerton, Fullerton, California, United States

  • Los Angeles Hematology Oncology Medical Group, Los Angeles, California, United States

  • Lynn Cancer Center, Boca Raton, Florida, United States

  • Miami Cancer Center, Miami, Florida, United States

  • Norton Cancer Institute - Downtown, Louisville, Kentucky, United States

  • University of Maryland Greenebaum Cancer Center, Baltimore, Maryland, United States

  • Washington University - Siteman Cancer Center, St Louis, Missouri, United States

  • Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States

  • Salib Oncology, Easton, Pennsylvania, United States

  • University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, United States

  • Daycare Angels under AOH, Mumbai, Maharashtra, India

    Contact: Study coordinator (Suresh Advani) · shadvani2000@yahoo.com · 9122-565-7323

  • Grant Medical Foundation Ruby Hall Clinic, Pune, Maharashtra, India

  • Basavatarakam Indo American Cancer Hospital & Research Institute, Hyderabad, Telangana, India

    Contact: Study coordinator (M.V.T Krishna Mohan) · mvtkm@yahoo.com · +9140-23550015
צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)